Hana Biosciences, Inc.

(NASDAQ:HNAB)

0.280

+0.010 (3.70%)

Jan 07 - Close

Open
0.270
High
0.280
Low
0.270
Vol.
18.01K
Mkt Cap
8.74M
52Wk High
1.48
52Wk Low
0.15
Avg. Vol.
54.60K
P/E (Trailing)
-0.46
Beta
0.00
Short %
0.10%
Div. Yield
—

After-Hours 0.28 0.00 (0.00%) Wed, 7 Jan 2009 7:40 PM

Company Profile

Hana Biosciences, Inc.

7000 Shoreline Ct.,

South San Francisco, CA 94080

United States - Map

Phone: (650) 588-6404

Fax: (650) 588-2787

Website: www.hanabiosciences.com

State of incorporation: Delaware

CEO: Dr. Steven R. Deitcher, M.D.

Employees: 27

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Biopharmaceutical company focused on cancer prod.

a biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care.

Recent news for HNAB

Member sentiment (?)    Neutral

- MarketGuru Blog network-

No members own HNAB

Recent opinions on HNAB

No recent Opinions for HNAB